Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Gruenenthal
Gruenenthal
Activities:
Manufacturing
Research & Development
X
LinkedIn
Trending Articles
IMPACT CKD model reveals the escalating toll of chronic kidney disease
The model projects up to 125 million of the population across eight countries to suffer from chronic kidney disease by 2032
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Isospec Analytics launches biomolecular analysis technology to identify unknown molecules
The novel technology optimises the identification process of unknown molecules compared to mass analysis
Building strong foundations for a resilient and planet-friendly future
Having recently released its inaugural environmental, social and governance (ESG) report, Dr Kevin Robinson caught up with Gigi Bat-Erdene, Global ESG Program Manager at PCI...
ten23 health and Ypsomed collaborate to commercialise the YpsoDose patch injector
The partnership will bring the drug delivery device to the pharmaceutical market quicker, whilst reducing development risks
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Research & Development
Catalent and Grünenthal announce manufacturing collaboration
In this phase, Catalent supported Grünenthal with the development of a bioavailability enhanced formulation
Grünenthal appoints Gabriel Baertschi as Chairman and Chief Executive
He follows Prof. Dr Eric-Paul Paques who retires after 23 years with the company
Finance
Grünenthal Group agrees to buy Almirall's operations in Mexico
The deal is a key element of the German Group's strategy to strengthen its footprint in Latin America
Finance
Gruenenthal completes acquisition of Empresas Andromaco
Almost doubles sales in Latin America
Research & Development
Xention and Grünenthal sign research agreement
To focus on new drugs to treat chronic pain
Subscribe now